These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 18384708)

  • 21. New federal guidelines for physician-pharmaceutical industry relations: the politics of policy formation.
    Chimonas S; Rothman DJ
    Health Aff (Millwood); 2005; 24(4):949-60. PubMed ID: 16136634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing stakeholder opinion on relations between cancer patient groups and pharmaceutical companies in Europe.
    Leto di Priolo S; Fehervary A; Riggins P; Redmond K
    Patient; 2012; 5(2):127-39. PubMed ID: 22299759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethics orientation as a mediator of organizational integrity in health services organizations.
    Proenca EJ
    Health Care Manage Rev; 2004; 29(1):40-50. PubMed ID: 14992483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Industry and the profession of medicine: balancing appropriate relationships with the need for innovation.
    Lewin J; Arend TE
    J Vasc Surg; 2011 Sep; 54(3 Suppl):47S-9S. PubMed ID: 21872116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharma on the hot seat.
    Huberfeld N
    J Health Law; 2007; 40(2):241-65. PubMed ID: 17849829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mental health nursing students' relationships with the pharmaceutical industry.
    Ashmore R; Carver N; Banks D
    Nurse Educ Today; 2007 Aug; 27(6):551-60. PubMed ID: 17113686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug industry paid £41m to UK healthcare professionals last year.
    Wise J
    BMJ; 2015 Jul; 351():h3909. PubMed ID: 26187820
    [No Abstract]   [Full Text] [Related]  

  • 29. New developments in managing physician-industry relationships.
    Rothman DJ; Chimonas S
    JAMA; 2008 Sep; 300(9):1067-9. PubMed ID: 18768417
    [No Abstract]   [Full Text] [Related]  

  • 30. Using the literature in developing McGill's guidelines for interactions between residents and the pharmaceutical industry.
    Wazana A; Granich A; Primeau F; Bhanji NH; Jalbert M
    Acad Med; 2004 Nov; 79(11):1033-40. PubMed ID: 15504767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality management benchmarking: FDA compliance in pharmaceutical industry.
    Jochem R; Landgraf K
    Int J Health Care Qual Assur; 2010; 23(8):690-8. PubMed ID: 21125964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dangerous liaisons: doctors-in-training and the pharmaceutical industry.
    Pokorny AM; Gittins CB
    Intern Med J; 2015 Oct; 45(10):1085-8. PubMed ID: 26429220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ethics of pharmaceutical industry gift-giving: the role of a professional association.
    Morin K; Morse LJ
    Am J Bioeth; 2003; 3(3):54-5. PubMed ID: 14594494
    [No Abstract]   [Full Text] [Related]  

  • 34. Solicitation of information and recommendations for developing OIG compliance program guidance for certain Medicare+Choice organizations--OIG, HHS. Notice.
    Fed Regist; 1998 Sep; 63(183):50577-8. PubMed ID: 10185802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solicitation of information and recommendations for developing OIG compliance program guidance for the durable medical equipment industry--HHS. Notice.
    Fed Regist; 1998 Aug; 63(152):42409-10. PubMed ID: 10181728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution.
    Studdert DM; Mello MM; Brennan TA
    N Engl J Med; 2004 Oct; 351(18):1891-900. PubMed ID: 15509824
    [No Abstract]   [Full Text] [Related]  

  • 37. Paediatricians and the pharmaceutical industry: an industry perspective of the challenges ahead.
    Leather DA; Davis SC
    Paediatr Respir Rev; 2006 Mar; 7(1):60-6. PubMed ID: 16473819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.
    Eddy K; Jordan Z; Stephenson M
    JBI Database System Rev Implement Rep; 2016 Apr; 14(4):96-137. PubMed ID: 27532314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of residency program guidelines for interaction with the pharmaceutical industry. Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont.
    CMAJ; 1993 Aug; 149(4):405-8. PubMed ID: 8348422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.